Andrew R. Robbins - Jun 22, 2022 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HARP	Director Stock Option (Right to Buy)	Award	$0	+10.2K		$0.00	10.2K	Jun 22, 2022	Common Stock	10.2K	$2.01	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.